Trxade Group (NASDAQ:MEDS) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.08) by 62.5 percent. This is a 23.53 percent increase over losses of $(0.17) per share from the same period last year.
Preview: Stellus Cap Investment’s Earnings
Stellus Cap Investment (NYSE:SCM) is set to give its latest quarterly earnings report on Tuesday, 2023-05-09. Here’s what…